TY - JOUR AU - Wooster, R. AU - Weber, B. PY - 2003 DA - 2003// TI - Breast and ovarian cancer JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMra012284 DO - 10.1056/NEJMra012284 ID - Wooster2003 ER - TY - JOUR AU - Senkus, E. AU - Kyriakides, S. AU - Ohno, S. AU - Penault-Llorca, F. AU - Poortmans, P. AU - Rutgers, E. PY - 2015 DA - 2015// TI - Primary breast cancer: ESMO clinical practice guidelines JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv298 DO - 10.1093/annonc/mdv298 ID - Senkus2015 ER - TY - JOUR AU - Cardoso, F. AU - Costa, A. AU - Senkus, E. AU - Aapro, M. AU - André, F. PY - 2017 DA - 2017// TI - Barrios CH et al. 3rd ESO–ESMO international consensus guidelines for advanced breast Cancer (ABC 3) JO - Ann Oncol VL - 28 ID - Cardoso2017 ER - TY - JOUR AU - Byrski, T. AU - Gronwald, J. AU - Huzarski, T. AU - Grzybowska, E. AU - Budryk, M. AU - Stawicka, M. PY - 2010 DA - 2010// TI - Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2008.20.7019 DO - 10.1200/JCO.2008.20.7019 ID - Byrski2010 ER - TY - JOUR AU - Byrski, T. AU - Huzarski, R. AU - Dent, E. AU - Marczyk, M. AU - Jasiowka, J. AU - Gronwald, J. PY - 2014 DA - 2014// TI - Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients JO - Breast Cancer Res Treat VL - 147 UR - https://doi.org/10.1007/s10549-014-3100-x DO - 10.1007/s10549-014-3100-x ID - Byrski2014 ER - TY - JOUR AU - Moysenko, V. AU - Dolmatov, G. AU - Moiseyenko, F. AU - Ivantsov, A. AU - Volkov, N. AU - Chubenko, V. PY - 2015 DA - 2015// TI - High efficacy of cisplatin neoadjuvant therapy in a prospective series of patients carrying BRCA1 germ-line mutation JO - Med Oncol VL - 32 UR - https://doi.org/10.1007/s12032-015-0514-1 DO - 10.1007/s12032-015-0514-1 ID - Moysenko2015 ER - TY - JOUR AU - Tutt, A. AU - Ellis, P. AU - Kilburn, L. AU - Gilett, C. AU - Pinder, S. AU - Abraham, J. PY - 2014 DA - 2014// TI - The TNT trial: a randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic recurrent or locally advanced triple negative or BRCA1/2 breast cancer JO - Cancer Res VL - 1 ID - Tutt2014 ER - TY - JOUR AU - Byrski, T. AU - Dent, R. AU - Blecharz, P. AU - Foszczynska-Kloda, M. AU - Gronwald, J. AU - Huzarski, T. PY - 2012 DA - 2012// TI - Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer JO - Breast Cancer Res VL - 20 UR - https://doi.org/10.1186/bcr3231 DO - 10.1186/bcr3231 ID - Byrski2012 ER - TY - JOUR AU - Isakoff, S. J. AU - Mayer, E. L. AU - He, L. AU - Traina, T. A. AU - Carey, L. A. AU - Krag, K. J. PY - 2015 DA - 2015// TI - TBCRC009: a multicenter phase II clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast Cancer JO - J Clin Oncol VL - 10 UR - https://doi.org/10.1200/JCO.2014.57.6660 DO - 10.1200/JCO.2014.57.6660 ID - Isakoff2015 ER - TY - JOUR AU - Couch, F. J. AU - Hart, S. N. AU - Sharma, P. AU - Toland, A. E. AU - Wang, X. AU - Miron, P. PY - 2015 DA - 2015// TI - Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer JO - J Clin Oncol VL - 1 UR - https://doi.org/10.1200/JCO.2014.57.1414 DO - 10.1200/JCO.2014.57.1414 ID - Couch2015 ER - TY - JOUR AU - Maksimenko, J. AU - Irmejs, A. AU - Nakazawa-Miklasevica, M. AU - Melbarde-Gorkusa, I. AU - Trofimovics, G. AU - Gardovskis, J. PY - 2014 DA - 2014// TI - Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer JO - Oncol Lett VL - 7 UR - https://doi.org/10.3892/ol.2013.1684 DO - 10.3892/ol.2013.1684 ID - Maksimenko2014 ER - TY - JOUR AU - McWhinney, S. R. AU - Goldberg, R. M. AU - McLeod, H. L. PY - 2014 DA - 2014// TI - Platinum neurotoxicity pharmacogenetics JO - Mol Cancer Ther VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-08-0840 DO - 10.1158/1535-7163.MCT-08-0840 ID - McWhinney2014 ER - TY - JOUR AU - Sharma, P. AU - López-Tarruella, S. AU - García-Saenz, J. A. AU - Ward, C. AU - Connor, C. S. AU - Gómez, H. L. PY - 2017 DA - 2017// TI - Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast Cancer: combined analysis of two cohorts JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-0162 DO - 10.1158/1078-0432.CCR-16-0162 ID - Sharma2017 ER -